SARS-COV-2 Vaccinations in RMD patients
The EULAR Task Force on COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021).
The information addresses questions, including considerations regarding vaccination effectiveness and safety, the third vaccination dose, booster vaccination, combination with Influenza and Pneumococcus vaccination, among other frequently asked questions by people with RMDs.
EULAR President, Prof Annamaria Iagnocco, invites you to share the link with your axSpA community.
Other NEWS
Introducing our new Trustees
Following our recent call for new Trustees, we are delighted …
Read More
Making Access Happen
As we know, timely access to affordable and appropriate medications …
Read More
Focusing on Latin America Copy
At ASIF we are always working to increase our understanding, …
Read More